Telephone
61.3.9918.5555
Address
Level 7 737 Bourke Street Docklands, Victoria (VIC) 3008
Description
EBOS Group Ltd. engages in the provision of healthcare and animal care products and services. It operates through the following segments: Healthcare, Animal Care, and Corporate. The Healthcare segment incorporates the sale of healthcare products in a range of sectors, own brands, retail healthcare and wholesale activities. The Animal Care segment sells animal care products in a range of sectors, own brands, retail and wholesale activities. The Corporate segment includes net funding costs and central administration expenses. The company was founded on September 11, 1922 and is headquartered in Docklands, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 28.75 - 38.09
Trade Value (12mth)
AU$410,938.00
1 week
-1.61%
1 month
-9.82%
YTD
-0.21%
1 year
-2.71%
All time high
45.77
EPS 3 yr Growth
24.80%
EBITDA Margin
4.60%
Operating Cashflow
$348m
Free Cash Flow Return
10.10%
ROIC
7.90%
Interest Coverage
6.10
Quick Ratio
0.60
Shares on Issue (Fully Dilluted)
194m
HALO Sector
Healthcare
Next Company Report Date
26-Aug-25
Ex Dividend Date (est.)
27-Feb-25
Next Dividend Pay Date (est.)
21-Mar-25
Reporting Currency
AUD
Short Sell (% of issue)
0.42
Date | Announcements |
---|---|
10 March 25 |
Update - Dividend/Distribution - EBO
×
Update - Dividend/Distribution - EBO |
10 March 25 |
DRP Strike Price
×
DRP Strike Price |
19 February 25 |
ASX Appendix 4D
×
ASX Appendix 4D |
19 February 25 |
Half Year Results Media Release
×
Half Year Results Media Release |
19 February 25 |
Investor Presentation
×
Investor Presentation |
19 February 25 |
Interim Report
×
Interim Report |
19 February 25 |
NZX Results Announcement
×
NZX Results Announcement |
19 February 25 |
NZX Distribution Notice
×
NZX Distribution Notice |
19 February 25 |
Directors Declaration
×
Directors Declaration |
19 February 25 |
Shareholders Report
×
Shareholders Report |
19 February 25 |
EBOS Leadership Transition
×
EBOS Leadership Transition |
19 February 25 |
Dividend/Distribution - EBO
×
Dividend/Distribution - EBO |
18 February 25 |
Application for quotation of securities - EBO
×
Application for quotation of securities - EBO |
18 February 25 |
NZX Capital Change Notice
×
NZX Capital Change Notice |
03 February 25 |
ASX Appendix 3X
×
ASX Appendix 3X |
22 January 25 |
Senior Management Announcement
×
Senior Management Announcement |
14 January 25 |
Advance Notice - Interim Results
×
Advance Notice - Interim Results |
14 January 25 |
Application for quotation of securities - EBO
×
Application for quotation of securities - EBO |
14 January 25 |
NZX Capital Change Notice
×
NZX Capital Change Notice |
03 January 25 |
ASX Appendix 3X
×
ASX Appendix 3X |
23 December 24 |
Coline McConville appointed as an independent director
×
Coline McConville appointed as an independent director |
20 December 24 |
EBOS welcomes finalisation of first PWA
×
EBOS welcomes finalisation of first PWA |
17 December 24 |
Notification of cessation of securities - EBO
×
Notification of cessation of securities - EBO |
17 December 24 |
NZX Performance Rights Update
×
NZX Performance Rights Update |
16 December 24 |
Application for quotation of securities - EBO
×
Application for quotation of securities - EBO |
16 December 24 |
NZX Capital Change Notice
×
NZX Capital Change Notice |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.